Parkinson’s Disease and Photobiomodulation: Potential for Treatment
By Brian Bicknell, Ann Liebert, and Geoffrey Herkes |mdpi.com | January 19, 2024
Parkinson’s disease is the second most common neurodegenerative disease and is increasingin incidence. The combination of motor and non-motor symptoms makes this a devastating disease for people with Parkinson’s disease and their care givers. Parkinson’s disease is characterised by mitochondrial dysfunction and neuronal death in the substantia nigra, a reduction in dopamine, accumulation of α-synuclein aggregates and neuroinflammation.
